These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis. Azevedo M, Castel-Branco MG, Oliveira JF, Ramos E, Delgado L, Almeida J. Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691 [Abstract] [Full Text] [Related]
8. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis. Verin P, Easty DL, Secchi A, Ciprandi G, Partouche P, Nemeth-Wasmer G, Brancato R, Harrisberg CJ, Estivin-Ebrardt C, Coster DJ, Apel AJ, Coroneo MT, Knorr M, Carmichael TR, Kent-Smith BT, Abrantes P, Leonardi A, Cerqueti PM, Modorati G, Martinez M. Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563 [Abstract] [Full Text] [Related]
10. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Dechant KL, Goa KL. Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851 [Abstract] [Full Text] [Related]
12. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team. Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738 [Abstract] [Full Text] [Related]
18. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis. Davies BH, Mullins J. Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022 [Abstract] [Full Text] [Related]